Castle Wealth Management’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6K | Buy |
44,005
+625
| +1% | +$194 | 0.01% | 122 |
|
|
2025
Q1 | $18.3K | Hold |
43,380
| – | – | 0.01% | 126 |
|
|
2024
Q4 | $30.4K | Hold |
43,380
| – | – | 0.01% | 117 |
|
|
2024
Q3 | $20.3K | Hold |
43,380
| – | – | 0.01% | 121 |
|
|
2024
Q2 | $72K | Hold |
43,380
| – | – | 0.03% | 116 |
|
|
2024
Q1 | $79K | Hold |
43,380
| – | – | 0.04% | 118 |
|
|
2023
Q4 | $80.3K | Hold |
43,380
| – | – | 0.05% | 116 |
|
|
2023
Q3 | $62.5K | Hold |
43,380
| – | – | 0.04% | 100 |
|
|
2023
Q2 | $79.4K | Hold |
43,380
| – | – | 0.06% | 109 |
|
|
2023
Q1 | $85.9K | Hold |
43,380
| – | – | 0.07% | 105 |
|
|
2022
Q4 | $91.1K | Hold |
43,380
| – | – | 0.06% | 108 |
|
|
2022
Q3 | $82K | Hold |
43,380
| – | – | 0.05% | 159 |
|
|
2022
Q2 | $92K | Buy |
+43,380
| New | +$92K | 0.05% | 153 |
|